All you need to know on what has changed in Health Canada’s latest update and how to plan ahead ~Health Canada has published Version 4.0 of the Good Manufacturing Practices (GMP) Guide for Natural ...

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no ...

Guide covers five core components of 21 CFR Part 111 quality systems, common FDA cGMP violations, and tips for ...

Step-by-step guidance outlines the five core cGMP quality components, key FDA identity tests, and preparation for 2026 ...

Resource clarifies NSF GMP, USP Verified, and FDA cGMP standards and how GMP certification drives trust, retailer ...

Learn how ready-to-use vials and cartridges can aid in GMP Annex 1 Implementation and streamline compliance with EU ...

Sai Parenteral's allotment date is likely to be finalised today, March 30. Investors can check Sai Parenteral's IPO allotment ...

DoP again tweaks RPTUAS guidelines to liberalise modalities of implementation: Gireesh Babu, New Delhi Wednesday, April 8, 2026, 08:00 Hrs [IST] The Department of Pharmaceuticals ...

Comprehensive 2026 guide details DSHEA, 21 CFR Part 111 GMPs, NDI notifications, labeling, and FDA enforcement trends for supplement brand compliance IRVINE, CA ...

GMP Consulting Supports FDA Audits, SOPs, Testing, and GMP Readiness for Supplement Manufacturers IRVINE, CA, UNITED ...

Central Mine Planning & Design Institute sold its shares in the price band of Rs 163-172 apiece, applied for a minimum of 80 shares and its multiples to raise Rs 1,842 crore between March 20-24.

The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...